Evaluation of patient outcomes after acute myocardial infarction in France
French Cohort of Myocardial Infarction Evaluation
This study looks at how patients in France do after having a heart attack by collecting information on their care and recovery from hospitals and national health records.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 1 site (Paris) |
| Trial ID | NCT04050956 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the profiles, management, and follow-up of patients who experience acute myocardial infarction (AMI) in France. It involves a multicenter registry that collects data from patients admitted to cardiac intensive care units within 48 hours of symptom onset. The study will link hospital data with national databases to evaluate clinical outcomes and healthcare consumption over time. By analyzing these factors, the study seeks to understand their relationship with patient outcomes post-AMI.
Who should consider this trial
Good fit: Ideal candidates for this study are patients who have experienced an acute myocardial infarction within 48 hours of symptom onset.
Not a fit: Patients with iatrogenic myocardial infarction or those whose diagnosis is invalidated by another condition may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the understanding of AMI management and enhance patient care strategies.
How similar studies have performed: Other studies have shown success in evaluating patient outcomes in AMI, making this approach both relevant and necessary.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria:
* Myocardial infarction (MI) within 48h of symptom onset, characterized by the typical increased or fall of troponin (or CPKMB) associated with at least one of the following elements :
* Symptoms compatible with myocardial ischemia
* Appearance of pathological Q waves
* ST- T changes compatible with myocardial ischemia (ST segment elevation or depression, T-wave inversion)
* Written consent.
* Covered by French medical insurance ("Sécurité Sociale")
Exclusion Criteria:
* Iatrogenic MI defined as MI occurring within 48h of a therapeutic procedure
* AMI diagnosis invalidated in favor of another diagnosis
Where this trial is running
Paris
- Hôpital Bichat, AP-HP — Paris, France (Recruiting)
Study contacts
- Principal investigator: Philippe Gabriel STEG — Assistance Publique - Hôpitaux de Paris
- Study coordinator: Tabassome SIMON
- Email: tabassome.simon@aphp.fr
- Phone: 01 40 01 13 93
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.